La consellera de Sanidad Universal y Salud Pública, Ana Barceló, ha calificado «muy positivamente» la decisión de aprobar la nueva vacuna de Moderna y ha asegurado que la Comunitat Valenciana «está preparada para su administración apenas lleguen las primeras dosis» que, previsiblemente, será la próxima semana.
Entre enero y febrero se recibirán los primeros envíos de Moderna, que supondrán cerca de 50.000 dosis de esta segunda vacuna autorizada. Esto permitirá «acelerar el proceso de vacunación en los primeros estadios» que son las Residencias y los sanitarios de primera línea COVID-19, según la consellera.
A process that, at the end of this last Wednesday, had already been completed in 125 residences in the Valencian Community and that will be significantly accelerated in the coming days. In this sense, Health maintains its plan so that next Monday users and workers of all coronavirus-free residences in the Valencian Community are vaccinated.
This vaccine, developed by Moderna, prevents the disease caused by SARS-CoV-2 in people 18 years of age and older. It is administered in two doses with an interval of 28 days and its maintenance requires its refrigeration at 20 degrees below zero.
The authorization of Moderna's vaccine is based on a pivotal double-blind clinical trial (the vaccine or a placebo is administered masked in such a way as to prevent its identification with the naked eye), randomized, versus placebo, which included more than 30.000 adults over 18 years of age who were vaccinated with two doses of 100 micrograms, separated by an interval of 28 days.
In the intermediate analysis of the results, 196 cases of coronavirus disease were observed, 185 with placebo and 11 with the vaccine, which allowed estimating a vaccine efficacy of 94,1%.
